Collectively, our findings demonstrate that FAPα<sup>+</sup> macrophages mediate MM immune evasion via dual mechanisms, positioning them as promising therapeutic targets to potentiate anti-tumor immunotherapies. This evidence concerns the gene FAP and Miyoshi myopathy.